EP2820151
CANCER PATIENT SELECTION FOR ADMINISTRATION OF WNT SIGNALING INHIBITORS USING RNF43 MUTATION STATUS
:
EP einkaleyfi: Þýðing ekki lögð inn:
22.2.2013:
25.3.2020:
13707527.1
:
21.2.2033
:
CANCER PATIENT SELECTION FOR ADMINISTRATION OF WNT SIGNALING INHIBITORS USING RNF43 MUTATION STATUS
22.2.2013
25.3.2020
:
Novartis AG:
Lichtstrasse 35, 4056 Basel, CH
:
CONG, Feng:
Cambridge, MA 02139, US
:
HAO, Huaixiang:
Cambridge, MA 02139, US
:
HSIEH, Hsin-i:
San Diego, CA 92121, US
:
JIANG, Xiaomo:
Cambridge, MA 02139, US
:
LIU, Jun:
San Diego, CA 92121, US
:
NG, Nicholas:
San Diego, CA 92121, US
:
201261604290 P:
28.2.2012:
US
:
US2013027441:
22.2.2013
:
C12Q 1/68